Spallitta S I, Termine G, Stella M, Calistro V, Marozzi P
Divisione di Chirurgia d'Urgenza, Azienda Ospedaliera V. Cervello, Palermo.
Minerva Chir. 2000 Jan-Feb;55(1-2):77-87.
A case of a young male operated on for acute appendicitis due to a carcinoid of the base is reported. Since the tumor was infiltrating the resection margin of the appendix, the patient was later treated with a right hemicolectomy. Carcinoid tumor is unusual, but can be encountered several times during the career of a surgeon (1/200-300 appendicectomy). The tumor is more frequent in women (2-4:1), located at the tip of the appendix (62-78%) and has a diameter less than 1 cm in 70-95% of cases. It is more frequently diagnosed incidentally after an operation for acute appendicitis and occasionally during other procedures (colectomy, cholecystectomy, salpingectomy). Liver metastases are rare (< 2%), related to the dimension of the primitive tumor (21-100% when > 2 cm) and can cause a "carcinoid syndrome": flush, diarrhea bronchoconstriction, cardiac valve disease. Diagnosis is made by the pathologist and staging by conventional radiologic procedures (TAC, US), dosage of neuroendocrine mediators such as 24 hours urinary 5-HIAA. Nowadays 111In-octreotide scintigraphy (SRS) has an 86% sensitivity to detect the carcinoid and is useful for staging and for planning a surgical intervention. Simple appendectomy is adequate treatment for appendiceal carcinoids less than 1 cm in diameter. Adequate treatment for tumors greater than 2 cm is right hemicolectomy. A point of controversy is what to do for tumors in the 1 to 2 cm range. It seems that appendectomy alone is sufficient except in those cases when mesoappendiceal invasion is identified. When surgical margins after appendectomy are not free of tumor, additional surgery seems warranted. Carcinoid tumor of the appendix has a good prognosis with a 5-year-survival rate, of 85.9-100%. When liver metastases are encountered octreotide can relieve symptoms and sometimes the progression of the disease.
报告了一例因阑尾根部类癌接受急性阑尾炎手术的年轻男性病例。由于肿瘤侵犯阑尾切除边缘,患者后来接受了右半结肠切除术。类癌肿瘤并不常见,但在外科医生的职业生涯中可能会遇到几次(每200 - 300例阑尾切除术中出现1例)。该肿瘤在女性中更为常见(2 - 4:1),位于阑尾尖端(62 - 78%),70 - 95%的病例直径小于1厘米。它更常于急性阑尾炎手术后偶然诊断出来,偶尔也在其他手术(结肠切除术、胆囊切除术、输卵管切除术)中被发现。肝转移很少见(< 2%),与原发肿瘤大小有关(肿瘤> 2厘米时发生率为21 - 100%),可导致“类癌综合征”:潮红、腹泻、支气管收缩、心脏瓣膜病。诊断由病理学家做出,分期通过传统放射学检查(CT、超声)以及神经内分泌介质的测定,如24小时尿5 - HIAA。如今,铟 - 111奥曲肽闪烁扫描(SRS)检测类癌的敏感性为86%,对分期和规划手术干预很有用。对于直径小于1厘米的阑尾类癌,单纯阑尾切除术是足够的治疗方法。对于直径大于2厘米的肿瘤,合适的治疗方法是右半结肠切除术。一个有争议的问题是对于直径在1至2厘米范围内的肿瘤该如何处理。似乎除了发现阑尾系膜受侵的情况外,单纯阑尾切除术就足够了。当阑尾切除术后手术切缘有肿瘤残留时,似乎有必要进行额外的手术。阑尾类癌预后良好,5年生存率为85.9 - 100%。当出现肝转移时,奥曲肽可缓解症状,有时还能延缓疾病进展。